• This record comes from PubMed

Intravenous insulin therapy during lung resection does not affect lung function or surfactant proteins

. 2014 Oct 02 ; 14 () : 155. [epub] 20141002

Language English Country Great Britain, England Media electronic

Document type Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't

BACKGROUND: The surgical resection of lung disrupts glucose homeostasis and causes hyperglycemia, as in any other major surgery or critical illness. We performed a prospective study where we carefully lowered hyperglycemia by insulin administration during the surgery, and for the first time we monitored immediate insulin effects on lung physiology and gene transcription. METHODS: The levels of blood gases (pH, pCO2, pO2, HCO3-, HCO3- std, base excess, FiO2, and pO2/FiO2) were measured at the beginning of surgery, at the end of surgery, and two hours after. Samples of healthy lung tissue surrounding the tumour were obtained during the surgery, anonymized and sent for subsequent blinded qPCR analysis (mRNA levels of surfactant proteins A1, A2, B, C and D were measured). This study was done on a cohort of 64 patients who underwent lung resection. Patients were randomly divided, and half of them received insulin treatment during the surgery. RESULTS: We demonstrated for the first time that insulin administered intravenously during lung resection does not affect levels of blood gases. Furthermore, it does not induce immediate changes in the expression of surfactant proteins. CONCLUSION: According to our observations, short insulin treatment applied intravenously during resection does not affect the quality of breathing.

See more in PubMed

Bagshaw SM, Egi M, George C, Bellomo R, Committee ANZICSDM Early blood glucose control and mortality in critically ill patients in Australia. Crit Care Med. 2009;37(2):463–470. doi: 10.1097/CCM.0b013e318194b097. PubMed DOI

Kwon S, Thompson R, Dellinger P, Yanez D, Farrohki E, Flum D. Importance of perioperative glycemic control in general surgery: a report from the surgical care and outcomes assessment program. Ann Surg. 2013;257(1):8–14. doi: 10.1097/SLA.0b013e31827b6bbc. PubMed DOI PMC

Rucka Z, Vanhara P, Koutna I, Tesarova L, Potesilova M, Stejskal S, Simara P, Dolezel J, Zvonicek V, Coufal O, Capov I. Differential effects of insulin and dexamethasone on pulmonary surfactant-associated genes and proteins in A549 and H441 cells and lung tissue. Int J Mol Med. 2013;32(1):211–218. PubMed

Dekowski S, Snyder J. Insulin regulation of messenger ribonucleic acid for the surfactant-associated proteins in human fetal lung in vitro. Endocrinology. 1992;131(2):669–676. PubMed

Kumar A, Snyder J. Differential regulation of SP-A1 and SP-A2 genes by cAMP, glucocorticoids, and insulin. Am J Physiol. 1998;274(2 Pt 1):L177–L185. PubMed

Miakotina OL, Goss KL, Snyder JM. Insulin utilizes the PI 3-kinase pathway to inhibit SP-A gene expression in lung epithelial cells. Respir Res. 2002;3:27. doi: 10.1186/rr191. PubMed DOI PMC

Denham M, Conley BJ, Olsson F, Gulluyan L, Cole TJ, Mollard R. A murine respiratory-inducing niche displays variable efficiency across human and mouse embryonic stem cell species. Am J Physiol Lung Cell Mol Physiol. 2007;292(5):L1241–L1247. doi: 10.1152/ajplung.00440.2006. PubMed DOI

van Iwaarden F, Welmers B, Verhoef J, Haagsman H, van Golde L. Pulmonary surfactant protein A enhances the host-defense mechanism of rat alveolar macrophages. Am J Respir Cell Mol Biol. 1990;2(1):91–98. doi: 10.1165/ajrcmb/2.1.91. PubMed DOI

Finfer S, Chittock D, Su S, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson W, Hébert P, Heritier S, Heyland D, McArthur C, McDonald E, Mitchell I, Myburgh J, Norton R, Potter J, Robinson B, Ronco J. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283–1297. doi: 10.1056/NEJMoa0810625. PubMed DOI

Mowery NT, Gunter OL, Kauffmann RM, Diaz JJ, Collier BC, May AK. Duration of time on intensive insulin therapy predicts severe hypoglycemia in the surgically critically ill population. World J Surg. 2012;36(2):270–277. doi: 10.1007/s00268-011-1356-4. PubMed DOI

Mowery NT, Guillamondegui OD, Gunter OL, Diaz JJ, Collier BR, Dossett LA, Dortch MJ, May AK. Severe hypoglycemia while on intensive insulin therapy is not an independent predictor of death after trauma. J Trauma. 2010;68(2):342–347. doi: 10.1097/TA.0b013e3181c825f2. PubMed DOI

Krinsley J, Schultz MJ, Spronk PE, van Braam Houckgeest F, van der Sluijs JP, Mélot C, Preiser JC, Preiser JC. Mild hypoglycemia is strongly associated with increased intensive care unit length of stay. CMAJ. 2011;1:49. PubMed PMC

den Berghe GV. Intensive insulin therapy in the ICU-reconciling the evidence. Nat Rev Endocrinol. 2012;8(6):374–378. PubMed

Preiser JC, Devos P, Ruiz-Santana S, Mélot C, Annane D, Groeneveld J, Iapichino G, Leverve X, Nitenberg G, Singer P, Wernerman J, Joannidis M, Stecher A, Chioléro R. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med. 2009;35(10):1738–1748. doi: 10.1007/s00134-009-1585-2. PubMed DOI

Griesdale DE, de Souza RJ, van Dam RM, Heyland DK, Cook DJ, Malhotra A, Dhaliwal R, Henderson WR, Chittock DR, Finfer S, Talmor D. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ. 2009;180(8):821–827. doi: 10.1503/cmaj.090206. PubMed DOI PMC

Astrup P, Jorgensen K, Andersen OS, ENGEL K. The acid-base metabolism. A new approach Lancet. 1960;1(7133):1035–1039. PubMed

BAER DM. Acid-base disorders. The clinical use of the astrup method of determining ph, Pco2 and base excess. Calif Med. 1964;101:439–444. PubMed PMC

JORGENSEN K, ASTRUP P. Standard bicarbonate, its clinical significance, and a new method for its determination. Scand J Clin Lab Invest. 1957;9(2):122–132. doi: 10.3109/00365515709101210. PubMed DOI

Van den Berghe G, Schetz M, Vlasselaers D, Hermans G, Wilmer A, Bouillon R, Mesotten D. Clinical review: Intensive insulin therapy in critically ill patients: NICE-SUGAR or Leuven blood glucose target? J Clin Endocrinol Metab. 2009;94(9):3163–3170. doi: 10.1210/jc.2009-0663. PubMed DOI

Fleige S, Pfaffl MW. RNA integrity and the effect on the real-time qRT-PCR performance. Mol Aspects Med. 2006;27(2–3):126–139. doi: 10.1016/j.mam.2005.12.003. PubMed DOI

Liu D, Chen S, Liu H. Choice of endogenous control for gene expression in nonsmall cell lung cancer. Eur Respir J. 2005;26(6):1002–1008. doi: 10.1183/09031936.05.00050205. PubMed DOI

Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29(9):e45. doi: 10.1093/nar/29.9.e45. PubMed DOI PMC

Glasby MA, Huang CLH. Applied Physiology for Surgery and Critical Care. Oxford: Butterworth-Heinemann; 1995.

Schlichtig R, Grogono AW, Severinghaus JW. Human PaCO2 and standard base excess compensation for acid-base imbalance. Crit Care Med. 1998;26(7):1173–1179. doi: 10.1097/00003246-199807000-00015. PubMed DOI

Gibson RB. Effects Of Insulin And Glucose On Acid-Base Balance In Surgical Diabetic Patients. JAMA. 1926;86(16):1209. doi: 10.1001/jama.1926.26720420001009. DOI

Rymarz E, Mosiewicz J, Hanzlik J. The influence of glucose-insulin-kalium mixture (GIK) on the selected parameters of acid-base balance in acute myocardial infarction. Ann Univ Mariae Curie Sklodowska Med. 2001;56:1–6. PubMed

Miakotina OL, Dekowski SA, Snyder JM. Insulin inhibits surfactant protein A and B gene expression in the H441 cell line. Biochim Biophys Acta. 1998;1442(1):60–70. doi: 10.1016/S0167-4781(98)00121-3. PubMed DOI

Orgeig S, Morrison JL, Daniels CB. Prenatal development of the pulmonary surfactant system and the influence of hypoxia. Respir Physiol Neurobiol. 2011;178(1):129–145. doi: 10.1016/j.resp.2011.05.015. PubMed DOI

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...